source,author,title,description,url,urlToImage,publishedAt,content,Full Description
ETF Daily News,MarketBeat News,Bruker (NASDAQ:BRKR) Stock Rating Upgraded by The Goldman Sachs Group,"The Goldman Sachs Group upgraded shares of Bruker (NASDAQ:BRKR – Free Report) from a sell rating to a neutral rating in a research note issued to investors on Thursday, Marketbeat reports. They currently have $60.00 price objective on the medical research com…",https://www.etfdailynews.com/2024/12/08/bruker-nasdaqbrkr-stock-rating-upgraded-by-the-goldman-sachs-group/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bruker-co-logo.jpg&w=240&h=240&zc=2,2024-12-08T07:46:50Z,"The Goldman Sachs Group upgraded shares of Bruker (NASDAQ:BRKR – Free Report) from a sell rating to a neutral rating in a research note issued to investors on Thursday, Marketbeat reports. They curre… [+5348 chars]","Bruker (NASDAQ:BRKR) Stock Rating Upgraded by The Goldman Sachs Group - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options Bruker (NASDAQ:BRKR) Stock Rating Upgraded by The Goldman Sachs Group Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits The Goldman Sachs Group upgraded shares of Bruker ( NASDAQ:BRKR – Free Report ) from a sell rating to a neutral rating in a research note issued to investors on Thursday, Marketbeat reports. They currently have $60.00 price objective on the medical research company’s stock. A number of other analysts have also weighed in on BRKR. Wells Fargo & Company lowered their price target on shares of Bruker from $78.00 to $75.00 and set an “overweight” rating for the company in a report on Wednesday, November 6th. Citigroup lowered their target price on Bruker from $80.00 to $75.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Wolfe Research lowered Bruker from an “outperform” rating to a “peer perform” rating in a research note on Monday, September 30th. Barclays lowered their price objective on Bruker from $75.00 to $69.00 and set an “overweight” rating for the company in a research report on Wednesday, November 6th. Finally, TD Cowen dropped their price objective on Bruker from $72.00 to $70.00 and set a “hold” rating for the company in a report on Wednesday, November 6th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $79.36. Get Bruker alerts: Read Our Latest Report on Bruker Bruker Trading Up 0.8 % Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever BRKR stock opened at $58.96 on Thursday. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.66 and a quick ratio of 0.73. The stock has a market capitalization of $8.94 billion, a price-to-earnings ratio of 28.35, a P/E/G ratio of 3.99 and a beta of 1.18. The business has a fifty day moving average price of $59.61 and a 200 day moving average price of $63.39. Bruker has a fifty-two week low of $48.07 and a fifty-two week high of $94.86. Bruker ( NASDAQ:BRKR – Get Free Report ) last issued its quarterly earnings results on Tuesday, November 5th. The medical research company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.61 by ($0.01). The company had revenue of $864.40 million for the quarter, compared to analyst estimates of $866.46 million. Bruker had a return on equity of 21.52% and a net margin of 9.41%. The firm’s quarterly revenue was up 16.4% on a year-over-year basis. During the same quarter last year, the company earned $0.74 EPS. Analysts expect that Bruker will post 2.4 EPS for the current fiscal year. Bruker Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Monday, December 2nd will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.34%. The ex-dividend date is Monday, December 2nd. Bruker’s dividend payout ratio is 9.62%. Insider Activity In other news, CEO Frank H. Laukien bought 100,000 shares of the company’s stock in a transaction dated Monday, November 18th. The stock was bought at an average price of $50.14 per share, with a total value of $5,014,000.00. Following the completion of the acquisition, the chief executive officer now owns 38,439,563 shares of the company’s stock, valued at $1,927,359,688.82. This represents a 0.26 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link . Insiders own 28.30% of the company’s stock. Institutional Investors Weigh In On Bruker A number of large investors have recently added to or reduced their stakes in the stock. First Horizon Advisors Inc. lifted its position in shares of Bruker by 120.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 399 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 218 shares during the period. True Wealth Design LLC raised its stake in Bruker by 4,636.4% in the third quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock valued at $36,000 after purchasing an additional 510 shares in the last quarter. UMB Bank n.a. lifted its position in Bruker by 115.3% during the third quarter. UMB Bank n.a. now owns 661 shares of the medical research company’s stock worth $46,000 after purchasing an additional 354 shares during the period. Gordian Capital Singapore Pte Ltd acquired a new stake in Bruker during the second quarter worth about $52,000. Finally, GAMMA Investing LLC increased its holdings in Bruker by 81.0% in the 3rd quarter. GAMMA Investing LLC now owns 867 shares of the medical research company’s stock valued at $60,000 after buying an additional 388 shares during the period. Institutional investors and hedge funds own 79.52% of the company’s stock. About Bruker ( Get Free Report ) Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. Featured Articles Five stocks we like better than Bruker Learn Technical Analysis Skills to Master the Stock Market Fast-Growing Companies That Are Still Undervalued With Risk Tolerance, One Size Does Not Fit All Top Cybersecurity Stock Picks for 2025 Financial Services Stocks Investing Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE TeraWulf’s (WULF) “Buy” Rating Reiterated at Rosenblatt Securities NEXT HEADLINE » Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Liberty Global (NASDAQ:LBTYA) Stock Price You might be interested in: Rockefeller Capital Management L.P. Purchases 511 Shares of Datadog, Inc. Public Sector Pension Investment Board Grows Stock Holdings in Molina Healthcare, Inc. International Paper Shares Sold by Public Sector Pension Investment Board UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Five Below, Inc. Townsquare Capital LLC Makes New $174,000 Investment in Hope Bancorp, Inc. Rockefeller Capital Management L.P. Purchases Shares of 12,469 Abercrombie & Fitch Co. Daily Ratings & News for Bruker Complete the form below to receive the latest headlines and analysts' recommendations for Bruker with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Rockefeller Capital Management L.P. Purchases 511 Shares of Datadog, Inc. (NASDAQ:DDOG) Public Sector Pension Investment Board Grows Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH) International Paper (NYSE:IP) Shares Sold by Public Sector Pension Investment Board UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Five Below, Inc. (NASDAQ:FIVE) Townsquare Capital LLC Makes New $174,000 Investment in Hope Bancorp, Inc. (NASDAQ:HOPE) Rockefeller Capital Management L.P. Purchases Shares of 12,469 Abercrombie & Fitch Co. (NYSE:ANF) Public Sector Pension Investment Board Has $802,000 Stake in Expeditors International of Washington, Inc. (NASDAQ:EXPD) Public Sector Pension Investment Board Buys 1,200 Shares of Dollar General Co. (NYSE:DG) Capri Holdings Limited (NYSE:CPRI) Holdings Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Core & Main (NYSE:CNM) Price Target Raised to $57.00 nCino (NASDAQ:NCNO) Price Target Lowered to $42.00 at Robert W. Baird Dollar Tree (NASDAQ:DLTR) Upgraded at StockNews.com Public Sector Pension Investment Board Has $928,000 Stock Holdings in Waters Co. (NYSE:WAT) Rockefeller Capital Management L.P. Reduces Stake in Principal Financial Group, Inc. (NYSE:PFG) Public Sector Pension Investment Board Sells 5,293 Shares of Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) Public Sector Pension Investment Board Grows Holdings in Broadridge Financial Solutions, Inc. (NYSE:BR) Kellanova (NYSE:K) Shares Acquired by Public Sector Pension Investment Board Sprinklr (NYSE:CXM) Price Target Raised to $9.00 Dollar General (NYSE:DG) Rating Increased to Buy at Bank of America Asana (NYSE:ASAN) Stock Price Expected to Rise, Robert W. Baird Analyst Says © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,UnitedHealth Group (NYSE:UNH) Price Target Raised to $675.00,"UnitedHealth Group (NYSE:UNH – Free Report) had its price target boosted by Stephens from $605.00 to $675.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the healthcare conglomerat…",https://www.etfdailynews.com/2024/12/08/unitedhealth-group-nyseunh-price-target-raised-to-675-00/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/unitedhealth-group-incorporated-logo.png?v=20221020135718&w=240&h=240&zc=2,2024-12-08T07:46:50Z,"UnitedHealth Group (NYSE:UNH – Free Report) had its price target boosted by Stephens from $605.00 to $675.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm curr… [+5688 chars]","UnitedHealth Group (NYSE:UNH) Price Target Raised to $675.00 - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options UnitedHealth Group (NYSE:UNH) Price Target Raised to $675.00 Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits UnitedHealth Group ( NYSE:UNH – Free Report ) had its price target boosted by Stephens from $605.00 to $675.00 in a research note issued to investors on Thursday morning, Benzinga reports. The firm currently has an overweight rating on the healthcare conglomerate’s stock. A number of other analysts have also recently weighed in on the company. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Barclays lifted their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. Finally, Morgan Stanley decreased their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $626.84. Get UnitedHealth Group alerts: View Our Latest Stock Analysis on UNH UnitedHealth Group Trading Down 5.1 % Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever NYSE UNH opened at $549.62 on Thursday. The firm’s fifty day simple moving average is $586.84 and its 200-day simple moving average is $558.81. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market capitalization of $505.81 billion, a PE ratio of 35.81, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. UnitedHealth Group ( NYSE:UNH – Get Free Report ) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.56 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group will post 27.63 earnings per share for the current fiscal year. UnitedHealth Group Announces Dividend The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%. Institutional Investors Weigh In On UnitedHealth Group Hedge funds and other institutional investors have recently bought and sold shares of the business. Oddo BHF Asset Management Sas bought a new position in shares of UnitedHealth Group in the third quarter valued at about $44,742,000. Inspire Trust Co. N.A. lifted its position in shares of UnitedHealth Group by 2.8% during the third quarter. Inspire Trust Co. N.A. now owns 9,102 shares of the healthcare conglomerate’s stock worth $5,322,000 after purchasing an additional 251 shares in the last quarter. Beaird Harris Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 124.2% in the third quarter. Beaird Harris Wealth Management LLC now owns 287 shares of the healthcare conglomerate’s stock valued at $168,000 after purchasing an additional 159 shares in the last quarter. Franklin Resources Inc. boosted its position in UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after buying an additional 193,800 shares during the last quarter. Finally, Peapack Gladstone Financial Corp raised its position in shares of UnitedHealth Group by 1.7% during the third quarter. Peapack Gladstone Financial Corp now owns 70,718 shares of the healthcare conglomerate’s stock worth $41,348,000 after acquiring an additional 1,200 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds. About UnitedHealth Group ( Get Free Report ) UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. See Also Five stocks we like better than UnitedHealth Group How to trade using analyst ratings Fast-Growing Companies That Are Still Undervalued Differences Between Momentum Investing and Long Term Investing Top Cybersecurity Stock Picks for 2025 What Are Dividend Champions? How to Invest in the Champions Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE TeraWulf’s (WULF) “Buy” Rating Reiterated at Rosenblatt Securities NEXT HEADLINE » Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Liberty Global (NASDAQ:LBTYA) Stock Price You might be interested in: Rockefeller Capital Management L.P. Purchases 511 Shares of Datadog, Inc. Public Sector Pension Investment Board Grows Stock Holdings in Molina Healthcare, Inc. International Paper Shares Sold by Public Sector Pension Investment Board UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Five Below, Inc. Townsquare Capital LLC Makes New $174,000 Investment in Hope Bancorp, Inc. Rockefeller Capital Management L.P. Purchases Shares of 12,469 Abercrombie & Fitch Co. Daily Ratings & News for UnitedHealth Group Complete the form below to receive the latest headlines and analysts' recommendations for UnitedHealth Group with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Rockefeller Capital Management L.P. Purchases 511 Shares of Datadog, Inc. (NASDAQ:DDOG) Public Sector Pension Investment Board Grows Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH) International Paper (NYSE:IP) Shares Sold by Public Sector Pension Investment Board UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Five Below, Inc. (NASDAQ:FIVE) Townsquare Capital LLC Makes New $174,000 Investment in Hope Bancorp, Inc. (NASDAQ:HOPE) Rockefeller Capital Management L.P. Purchases Shares of 12,469 Abercrombie & Fitch Co. (NYSE:ANF) Public Sector Pension Investment Board Has $802,000 Stake in Expeditors International of Washington, Inc. (NASDAQ:EXPD) Public Sector Pension Investment Board Buys 1,200 Shares of Dollar General Co. (NYSE:DG) Capri Holdings Limited (NYSE:CPRI) Holdings Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Core & Main (NYSE:CNM) Price Target Raised to $57.00 nCino (NASDAQ:NCNO) Price Target Lowered to $42.00 at Robert W. Baird Dollar Tree (NASDAQ:DLTR) Upgraded at StockNews.com Public Sector Pension Investment Board Has $928,000 Stock Holdings in Waters Co. (NYSE:WAT) Rockefeller Capital Management L.P. Reduces Stake in Principal Financial Group, Inc. (NYSE:PFG) Public Sector Pension Investment Board Sells 5,293 Shares of Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) Public Sector Pension Investment Board Grows Holdings in Broadridge Financial Solutions, Inc. (NYSE:BR) Kellanova (NYSE:K) Shares Acquired by Public Sector Pension Investment Board Sprinklr (NYSE:CXM) Price Target Raised to $9.00 Dollar General (NYSE:DG) Rating Increased to Buy at Bank of America Asana (NYSE:ASAN) Stock Price Expected to Rise, Robert W. Baird Analyst Says © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,FY2025 EPS Estimates for Royal Bank of Canada Cut by Cormark,"Royal Bank of Canada (NYSE:RY – Free Report) (TSE:RY) – Stock analysts at Cormark reduced their FY2025 EPS estimates for Royal Bank of Canada in a research note issued on Thursday, December 5th. Cormark analyst L. Persaud now anticipates that the financial se…",https://www.etfdailynews.com/2024/12/08/fy2025-eps-estimates-for-royal-bank-of-canada-cut-by-cormark/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/rbc-capital-logo-1200x675.gif&w=240&h=240&zc=2,2024-12-08T07:46:50Z,"Royal Bank of Canada (NYSE:RY – Free Report) (TSE:RY) – Stock analysts at Cormark reduced their FY2025 EPS estimates for Royal Bank of Canada in a research note issued on Thursday, December 5th. Corm… [+4714 chars]","FY2025 EPS Estimates for Royal Bank of Canada Cut by Cormark - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options FY2025 EPS Estimates for Royal Bank of Canada Cut by Cormark Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Royal Bank of Canada ( NYSE:RY – Free Report ) (TSE:RY) – Stock analysts at Cormark reduced their FY2025 EPS estimates for Royal Bank of Canada in a research note issued on Thursday, December 5th. Cormark analyst L. Persaud now anticipates that the financial services provider will post earnings per share of $9.10 for the year, down from their previous forecast of $9.30. The consensus estimate for Royal Bank of Canada’s current full-year earnings is $9.22 per share. Cormark also issued estimates for Royal Bank of Canada’s FY2026 earnings at $9.85 EPS. Get Royal Bank of Canada alerts: Several other analysts have also recently issued reports on RY. Barclays upgraded shares of Royal Bank of Canada from an “equal weight” rating to an “overweight” rating in a research report on Thursday, November 21st. TD Securities lowered Royal Bank of Canada from a “buy” rating to a “hold” rating in a research note on Friday, November 15th. Finally, BMO Capital Markets dropped their target price on Royal Bank of Canada from $195.00 to $193.00 and set an “outperform” rating for the company in a report on Thursday. One investment analyst has rated the stock with a sell rating, one has given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $156.50. Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Get Our Latest Stock Report on Royal Bank of Canada Royal Bank of Canada Stock Performance NYSE:RY opened at $126.05 on Friday. The company has a market cap of $178.19 billion, a price-to-earnings ratio of 15.26, a PEG ratio of 1.86 and a beta of 0.86. Royal Bank of Canada has a 1 year low of $90.71 and a 1 year high of $128.05. The stock’s 50 day simple moving average is $123.82 and its two-hundred day simple moving average is $116.10. The company has a debt-to-equity ratio of 0.12, a current ratio of 0.87 and a quick ratio of 0.87. Institutional Investors Weigh In On Royal Bank of Canada Several large investors have recently modified their holdings of the business. FMR LLC raised its position in shares of Royal Bank of Canada by 75.8% in the 3rd quarter. FMR LLC now owns 17,866,021 shares of the financial services provider’s stock worth $2,229,834,000 after acquiring an additional 7,702,585 shares in the last quarter. National Bank of Canada FI grew its stake in Royal Bank of Canada by 16.7% in the second quarter. National Bank of Canada FI now owns 20,232,204 shares of the financial services provider’s stock valued at $2,141,681,000 after purchasing an additional 2,901,033 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in Royal Bank of Canada by 165.1% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,896,755 shares of the financial services provider’s stock worth $361,532,000 after purchasing an additional 1,804,022 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Royal Bank of Canada during the third quarter valued at about $153,217,000. Finally, Geode Capital Management LLC boosted its holdings in shares of Royal Bank of Canada by 9.3% in the 3rd quarter. Geode Capital Management LLC now owns 6,390,914 shares of the financial services provider’s stock valued at $805,616,000 after buying an additional 541,760 shares in the last quarter. Institutional investors own 45.31% of the company’s stock. Royal Bank of Canada Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 24th. Investors of record on Monday, January 27th will be issued a $1.0522 dividend. This is an increase from Royal Bank of Canada’s previous quarterly dividend of $1.03. This represents a $4.21 annualized dividend and a dividend yield of 3.34%. The ex-dividend date is Monday, January 27th. Royal Bank of Canada’s payout ratio is presently 50.85%. About Royal Bank of Canada ( Get Free Report ) Royal Bank of Canada operates as a diversified financial service company worldwide. The company's Personal & Commercial Banking segment offers checking and savings accounts, home equity financing, personal lending, private banking, indirect lending, including auto financing, mutual funds and self-directed brokerage accounts, guaranteed investment certificates, credit cards, and payment products and solutions; and lending, leasing, deposit, investment, foreign exchange, cash management, auto dealer financing, trade products, and services to small and medium-sized commercial businesses. Further Reading Five stocks we like better than Royal Bank of Canada 10 Best Airline Stocks to Buy Fast-Growing Companies That Are Still Undervalued Diversification Can Smooth Returns And Mitigate Portfolio Risk Top Cybersecurity Stock Picks for 2025 What is a Dividend Harvesting Strategy and How Can Investors Profit from it? Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for Royal Bank of Canada Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Royal Bank of Canada and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE TeraWulf’s (WULF) “Buy” Rating Reiterated at Rosenblatt Securities NEXT HEADLINE » Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Liberty Global (NASDAQ:LBTYA) Stock Price You might be interested in: Analysts Set Controladora Vuela Compañía de Aviación, S.A.B. de C.V. PT at $12.85 Ashtead Group Price Target Raised to GBX 7,300 InterContinental Hotels Group PLC Receives GBX 5,471 Average PT from Analysts WesBanco Upgraded at Raymond James Petco Health and Wellness Price Target Raised to $5.00 Petco Health and Wellness Price Target Raised to $6.00 Daily Ratings & News for Royal Bank of Canada Complete the form below to receive the latest headlines and analysts' recommendations for Royal Bank of Canada with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Analysts Set Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE:VLRS) PT at $12.85 Ashtead Group (LON:AHT) Price Target Raised to GBX 7,300 InterContinental Hotels Group PLC (LON:IHG) Receives GBX 5,471 Average PT from Analysts WesBanco (NASDAQ:WSBC) Upgraded at Raymond James Petco Health and Wellness (NASDAQ:WOOF) Price Target Raised to $5.00 Petco Health and Wellness (NASDAQ:WOOF) Price Target Raised to $6.00 Royal Bank of Canada Forecasts Strong Price Appreciation for K92 Mining Inc. (KNT.V) (CVE:KNT) Stock Trican Well Service Ltd. (TSE:TCW) Receives C$5.57 Average Price Target from Brokerages Verint Systems (NASDAQ:VRNT) Price Target Raised to $34.00 Petco Health and Wellness (NASDAQ:WOOF) Price Target Raised to $6.00 UroGen Pharma’s (URGN) “Buy” Rating Reiterated at D. Boral Capital Petco Health and Wellness (NASDAQ:WOOF) Price Target Raised to $6.00 SilverCrest Metals (CVE:SIL) Price Target Raised to C$13.00 at Royal Bank of Canada Zynex’s (ZYXI) “Buy” Rating Reiterated at HC Wainwright Legal & General Group (LON:LGEN) Price Target Raised to GBX 295 Halma (LON:HLMA) Upgraded at JPMorgan Chase & Co. Quadrise’s (QED) “House Stock” Rating Reiterated at Shore Capital M&G’s (MNG) “Hold” Rating Reiterated at Deutsche Bank Aktiengesellschaft Blackstone Mortgage Trust, Inc. (NYSE:BXMT) Receives $20.08 Consensus PT from Brokerages The New York Times Company (NYSE:NYT) Receives Average Rating of “Moderate Buy” from Brokerages © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,Mobileye Global (NASDAQ:MBLY) Upgraded to Outperform at Wolfe Research,"Wolfe Research upgraded shares of Mobileye Global (NASDAQ:MBLY – Free Report) from a peer perform rating to an outperform rating in a research note published on Thursday, MarketBeat reports. Other analysts have also issued research reports about the stock. JP…",https://www.etfdailynews.com/2024/12/08/mobileye-global-nasdaqmbly-upgraded-to-outperform-at-wolfe-research/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/mobileye-global-inc-logo.jpg?v=20221101084311&w=240&h=240&zc=2,2024-12-08T07:46:50Z,"Wolfe Research upgraded shares of Mobileye Global (NASDAQ:MBLY – Free Report) from a peer perform rating to an outperform rating in a research note published on Thursday, MarketBeat reports.
Other a… [+3899 chars]","Mobileye Global (NASDAQ:MBLY) Upgraded to Outperform at Wolfe Research - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options Mobileye Global (NASDAQ:MBLY) Upgraded to Outperform at Wolfe Research Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Wolfe Research upgraded shares of Mobileye Global ( NASDAQ:MBLY – Free Report ) from a peer perform rating to an outperform rating in a research note published on Thursday, MarketBeat reports. Other analysts have also issued research reports about the stock. JPMorgan Chase & Co. reaffirmed an “underweight” rating and set a $10.00 target price (down previously from $16.00) on shares of Mobileye Global in a report on Monday, October 7th. Barclays decreased their price target on shares of Mobileye Global from $19.00 to $18.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Loop Capital assumed coverage on Mobileye Global in a research note on Tuesday, November 12th. They set a “buy” rating and a $20.00 price objective for the company. Royal Bank of Canada restated a “sector perform” rating and set a $11.00 target price on shares of Mobileye Global in a research report on Tuesday, November 26th. Finally, Robert W. Baird raised their price target on Mobileye Global from $17.00 to $18.00 and gave the company an “outperform” rating in a report on Friday, November 1st. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Mobileye Global currently has an average rating of “Hold” and an average target price of $23.14. Get Mobileye Global alerts: Get Our Latest Analysis on MBLY Mobileye Global Stock Down 0.6 % Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever MBLY stock opened at $17.00 on Thursday. The stock has a 50-day simple moving average of $14.89 and a two-hundred day simple moving average of $18.61. Mobileye Global has a twelve month low of $10.48 and a twelve month high of $44.48. The firm has a market capitalization of $13.79 billion, a PE ratio of -4.66 and a beta of 0.44. Institutional Trading of Mobileye Global A number of institutional investors have recently made changes to their positions in the stock. Rakuten Securities Inc. increased its stake in shares of Mobileye Global by 140.2% in the third quarter. Rakuten Securities Inc. now owns 1,818 shares of the company’s stock worth $25,000 after buying an additional 1,061 shares during the period. Quarry LP purchased a new position in shares of Mobileye Global in the third quarter valued at about $31,000. Cranbrook Wealth Management LLC purchased a new position in shares of Mobileye Global in the second quarter valued at about $84,000. Quest Partners LLC bought a new position in shares of Mobileye Global during the third quarter valued at about $102,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Mobileye Global by 1,019.9% during the second quarter. EverSource Wealth Advisors LLC now owns 3,819 shares of the company’s stock worth $107,000 after purchasing an additional 3,478 shares during the period. Hedge funds and other institutional investors own 13.25% of the company’s stock. About Mobileye Global ( Get Free Report ) Mobileye Global Inc develops and deploys advanced driver assistance systems (ADAS) and autonomous driving technologies and solutions worldwide. The company operates through Mobileye and Other segments. It offers Driver Assist comprising ADAS and autonomous vehicle solutions that covers safety features, such as real-time detection of road users, geometry, semantics, and markings to provide safety alerts and emergency interventions; Cloud-Enhanced Driver Assist, a solution for drivers with interpretations of a scene in real-time; Mobileye SuperVision Lite, a navigation and assisted driving solution; and Mobileye SuperVision, an operational point-to-point assisted driving navigation solution on various road types and includes cloud-based enhancements, such as road experience management. Read More Five stocks we like better than Mobileye Global Do Real Estate Investment Trusts Deserve a Place in Your Portfolio? Fast-Growing Companies That Are Still Undervalued What Are Dividends? Buy the Best Dividend Stocks Top Cybersecurity Stock Picks for 2025 What Does a Gap Up Mean in Stocks? How to Play the Gap Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for Mobileye Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobileye Global and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE TeraWulf’s (WULF) “Buy” Rating Reiterated at Rosenblatt Securities NEXT HEADLINE » Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Liberty Global (NASDAQ:LBTYA) Stock Price You might be interested in: Two Harbors Investment Corp. Receives $14.18 Average PT from Analysts Fidelity National Financial, Inc. Receives $63.60 Average Price Target from Analysts Kinder Morgan, Inc. Receives Consensus Rating of “Moderate Buy” from Analysts The Chemours Company Receives Consensus Recommendation of “Hold” from Brokerages First American Financial Co. Receives Consensus Recommendation of “Moderate Buy” from Analysts Helmerich & Payne, Inc. Given Consensus Rating of “Hold” by Analysts Daily Ratings & News for Mobileye Global Complete the form below to receive the latest headlines and analysts' recommendations for Mobileye Global with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Two Harbors Investment Corp. (NYSE:TWO) Receives $14.18 Average PT from Analysts Fidelity National Financial, Inc. (NYSE:FNF) Receives $63.60 Average Price Target from Analysts Kinder Morgan, Inc. (NYSE:KMI) Receives Consensus Rating of “Moderate Buy” from Analysts The Chemours Company (NYSE:CC) Receives Consensus Recommendation of “Hold” from Brokerages First American Financial Co. (NYSE:FAF) Receives Consensus Recommendation of “Moderate Buy” from Analysts Helmerich & Payne, Inc. (NYSE:HP) Given Consensus Rating of “Hold” by Analysts Verisk Analytics, Inc. (NASDAQ:VRSK) Receives $285.80 Average Target Price from Analysts PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $51.15 Consensus Target Price from Analysts Brokerages Set Yum! Brands, Inc. (NYSE:YUM) Target Price at $145.94 Southern Copper Co. (NYSE:SCCO) Given Consensus Rating of “Reduce” by Analysts JPMorgan Chase & Co. Forecasts Strong Price Appreciation for The Goldman Sachs Group (NYSE:GS) Stock JPMorgan Chase & Co. Cuts LyondellBasell Industries (NYSE:LYB) Price Target to $90.00 What is HC Wainwright’s Estimate for KALV FY2029 Earnings? JPMorgan Chase & Co. Cuts Gold Fields (NYSE:GFI) Price Target to $17.10 JPMorgan Chase & Co. Upgrades ProPetro (NYSE:PUMP) to “Neutral” StockNews.com Upgrades Ooma (NYSE:OOMA) to Strong-Buy Foot Locker (NYSE:FL) Price Target Lowered to $29.00 at Barclays Ambarella’s (AMBA) Buy Rating Reaffirmed at Rosenblatt Securities Rosenblatt Securities Forecasts Strong Price Appreciation for Canaan (NASDAQ:CAN) Stock Morgan Stanley (NYSE:MS) Given New $104.00 Price Target at JPMorgan Chase & Co. © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,Gates Industrial (NYSE:GTES) Upgraded by Barclays to “Overweight” Rating,"Barclays upgraded shares of Gates Industrial (NYSE:GTES – Free Report) from an equal weight rating to an overweight rating in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. The brokerage currently has $25.00 target price …",https://www.etfdailynews.com/2024/12/08/gates-industrial-nysegtes-upgraded-by-barclays-to-overweight-rating/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/gates-industrial-corp-plc-logo.jpg?v=20221118143933&w=240&h=240&zc=2,2024-12-08T07:46:50Z,"Barclays upgraded shares of Gates Industrial (NYSE:GTES – Free Report) from an equal weight rating to an overweight rating in a research note issued to investors on Thursday morning, MarketBeat Ratin… [+3568 chars]","Gates Industrial (NYSE:GTES) Upgraded by Barclays to “Overweight” Rating - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options Gates Industrial (NYSE:GTES) Upgraded by Barclays to “Overweight” Rating Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Barclays upgraded shares of Gates Industrial ( NYSE:GTES – Free Report ) from an equal weight rating to an overweight rating in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. The brokerage currently has $25.00 target price on the stock, up from their prior target price of $21.00. Other analysts have also issued reports about the company. Royal Bank of Canada upgraded Gates Industrial from a “sector perform” rating to an “outperform” rating and boosted their target price for the company from $20.00 to $22.00 in a research note on Monday, August 19th. Morgan Stanley assumed coverage on Gates Industrial in a research note on Friday, September 6th. They issued an “equal weight” rating and a $19.00 price objective on the stock. Evercore ISI increased their target price on shares of Gates Industrial from $15.00 to $16.00 and gave the stock an “in-line” rating in a research report on Monday, August 19th. Finally, KeyCorp boosted their price target on shares of Gates Industrial from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.30. Get Gates Industrial alerts: Check Out Our Latest Analysis on GTES Gates Industrial Trading Down 1.3 % Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever NYSE:GTES opened at $22.64 on Thursday. The firm’s 50 day moving average is $19.82 and its 200 day moving average is $17.92. Gates Industrial has a 12 month low of $11.22 and a 12 month high of $23.34. The stock has a market capitalization of $5.77 billion, a PE ratio of 27.28 and a beta of 1.38. The company has a current ratio of 3.02, a quick ratio of 2.11 and a debt-to-equity ratio of 0.70. Institutional Trading of Gates Industrial Institutional investors and hedge funds have recently bought and sold shares of the company. Headlands Technologies LLC grew its position in shares of Gates Industrial by 341.1% during the 2nd quarter. Headlands Technologies LLC now owns 1,707 shares of the company’s stock valued at $27,000 after purchasing an additional 1,320 shares in the last quarter. Venturi Wealth Management LLC boosted its stake in Gates Industrial by 35.9% during the third quarter. Venturi Wealth Management LLC now owns 3,079 shares of the company’s stock valued at $54,000 after buying an additional 814 shares during the period. Capital Performance Advisors LLP bought a new stake in Gates Industrial during the third quarter valued at $67,000. GAMMA Investing LLC grew its position in Gates Industrial by 333.9% during the third quarter. GAMMA Investing LLC now owns 3,896 shares of the company’s stock worth $68,000 after buying an additional 2,998 shares in the last quarter. Finally, Quarry LP bought a new position in Gates Industrial in the 3rd quarter worth about $71,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors. Gates Industrial Company Profile ( Get Free Report ) Gates Industrial Corporation PLC designs and manufactures power transmission equipment. Its products serves harsh and hazardous industries such as agriculture, construction, manufacturing and energy, to everyday consumer applications such as printers, power washers, automatic doors and vacuum cleaners and virtually every form of transportation. Read More Five stocks we like better than Gates Industrial What is a buyback in stocks? A comprehensive guide for investors Fast-Growing Companies That Are Still Undervalued What Are the FAANG Stocks and Are They Good Investments? Top Cybersecurity Stock Picks for 2025 What Are Dividend Challengers? Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for Gates Industrial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gates Industrial and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE TeraWulf’s (WULF) “Buy” Rating Reiterated at Rosenblatt Securities NEXT HEADLINE » Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Liberty Global (NASDAQ:LBTYA) Stock Price You might be interested in: Two Harbors Investment Corp. Receives $14.18 Average PT from Analysts Fidelity National Financial, Inc. Receives $63.60 Average Price Target from Analysts Kinder Morgan, Inc. Receives Consensus Rating of “Moderate Buy” from Analysts The Chemours Company Receives Consensus Recommendation of “Hold” from Brokerages First American Financial Co. Receives Consensus Recommendation of “Moderate Buy” from Analysts Helmerich & Payne, Inc. Given Consensus Rating of “Hold” by Analysts Daily Ratings & News for Gates Industrial Complete the form below to receive the latest headlines and analysts' recommendations for Gates Industrial with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Two Harbors Investment Corp. (NYSE:TWO) Receives $14.18 Average PT from Analysts Fidelity National Financial, Inc. (NYSE:FNF) Receives $63.60 Average Price Target from Analysts Kinder Morgan, Inc. (NYSE:KMI) Receives Consensus Rating of “Moderate Buy” from Analysts The Chemours Company (NYSE:CC) Receives Consensus Recommendation of “Hold” from Brokerages First American Financial Co. (NYSE:FAF) Receives Consensus Recommendation of “Moderate Buy” from Analysts Helmerich & Payne, Inc. (NYSE:HP) Given Consensus Rating of “Hold” by Analysts Verisk Analytics, Inc. (NASDAQ:VRSK) Receives $285.80 Average Target Price from Analysts PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $51.15 Consensus Target Price from Analysts Brokerages Set Yum! Brands, Inc. (NYSE:YUM) Target Price at $145.94 Southern Copper Co. (NYSE:SCCO) Given Consensus Rating of “Reduce” by Analysts JPMorgan Chase & Co. Forecasts Strong Price Appreciation for The Goldman Sachs Group (NYSE:GS) Stock JPMorgan Chase & Co. Cuts LyondellBasell Industries (NYSE:LYB) Price Target to $90.00 What is HC Wainwright’s Estimate for KALV FY2029 Earnings? JPMorgan Chase & Co. Cuts Gold Fields (NYSE:GFI) Price Target to $17.10 JPMorgan Chase & Co. Upgrades ProPetro (NYSE:PUMP) to “Neutral” StockNews.com Upgrades Ooma (NYSE:OOMA) to Strong-Buy Foot Locker (NYSE:FL) Price Target Lowered to $29.00 at Barclays Ambarella’s (AMBA) Buy Rating Reaffirmed at Rosenblatt Securities Rosenblatt Securities Forecasts Strong Price Appreciation for Canaan (NASDAQ:CAN) Stock Morgan Stanley (NYSE:MS) Given New $104.00 Price Target at JPMorgan Chase & Co. © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,Okta (NASDAQ:OKTA) Upgraded to Outperform at Sanford C. Bernstein,"Sanford C. Bernstein upgraded shares of Okta (NASDAQ:OKTA – Free Report) from a market perform rating to an outperform rating in a research note published on Thursday morning, MarketBeat reports. They currently have $129.00 target price on the stock, up from …",https://www.etfdailynews.com/2024/12/08/okta-nasdaqokta-upgraded-to-outperform-at-sanford-c-bernstein/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/okta-inc-logo.png?v=20240109091735&w=240&h=240&zc=2,2024-12-08T07:46:49Z,"Sanford C. Bernstein upgraded shares of Okta (NASDAQ:OKTA – Free Report) from a market perform rating to an outperform rating in a research note published on Thursday morning, MarketBeat reports. The… [+4653 chars]","Okta (NASDAQ:OKTA) Upgraded to Outperform at Sanford C. Bernstein - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options Okta (NASDAQ:OKTA) Upgraded to Outperform at Sanford C. Bernstein Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Sanford C. Bernstein upgraded shares of Okta ( NASDAQ:OKTA – Free Report ) from a market perform rating to an outperform rating in a research note published on Thursday morning, MarketBeat reports. They currently have $129.00 target price on the stock, up from their previous target price of $123.00. Other equities analysts have also recently issued reports about the company. Jefferies Financial Group boosted their target price on Okta from $85.00 to $100.00 and gave the company a “hold” rating in a research note on Wednesday. Piper Sandler upped their price objective on shares of Okta from $85.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday. Westpark Capital reaffirmed a “buy” rating and set a $140.00 target price on shares of Okta in a research note on Wednesday. Canaccord Genuity Group increased their price target on shares of Okta from $82.00 to $94.00 and gave the stock a “hold” rating in a research note on Wednesday. Finally, BTIG Research lifted their price objective on Okta from $98.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Okta currently has a consensus rating of “Hold” and an average price target of $103.77. Get Okta alerts: View Our Latest Research Report on Okta Okta Stock Up 1.5 % Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever NASDAQ OKTA opened at $84.79 on Thursday. Okta has a 1 year low of $70.56 and a 1 year high of $114.50. The stock has a market capitalization of $14.40 billion, a PE ratio of -242.26, a PEG ratio of 22.07 and a beta of 1.00. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.83 and a quick ratio of 1.83. The business’s 50-day moving average is $75.77 and its 200 day moving average is $84.04. Insiders Place Their Bets In other news, CEO Todd Mckinnon sold 224,533 shares of the company’s stock in a transaction dated Friday, October 18th. The shares were sold at an average price of $74.62, for a total value of $16,754,652.46. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink . Also, Director Jacques Frederic Kerrest sold 131,426 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $80.68, for a total transaction of $10,603,449.68. Following the completion of the sale, the director now directly owns 1,622 shares of the company’s stock, valued at approximately $130,862.96. This trade represents a 98.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders sold a total of 607,215 shares of company stock worth $46,304,810 over the last three months. 7.00% of the stock is currently owned by company insiders. Institutional Trading of Okta A number of large investors have recently modified their holdings of the company. Itau Unibanco Holding S.A. purchased a new position in Okta during the 3rd quarter valued at about $25,000. EverSource Wealth Advisors LLC increased its holdings in shares of Okta by 71.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 341 shares of the company’s stock valued at $36,000 after acquiring an additional 142 shares during the period. Future Financial Wealth Managment LLC purchased a new stake in shares of Okta during the 3rd quarter worth $26,000. Blue Trust Inc. lifted its position in shares of Okta by 105.5% during the third quarter. Blue Trust Inc. now owns 372 shares of the company’s stock valued at $28,000 after buying an additional 191 shares during the last quarter. Finally, Legacy Investment Solutions LLC bought a new stake in shares of Okta in the 3rd quarter valued at about $32,000. Hedge funds and other institutional investors own 86.64% of the company’s stock. Okta Company Profile ( Get Free Report ) Okta, Inc operates as an identity partner in the United States and internationally. The company offers Okta's suite of products and services used to manage and secure identities, such as Single Sign-On that enables users to access applications in the cloud or on-premises from various devices; Adaptive Multi-Factor Authentication provides a layer of security for cloud, mobile, web applications, and data; API Access Management enables organizations to secure APIs; Access Gateway enables organizations to extend Workforce Identity Cloud; and Okta Device Access enables end users to securely log in to devices with Okta credentials. Featured Articles Five stocks we like better than Okta Golden Cross Stocks: Pattern, Examples and Charts Fast-Growing Companies That Are Still Undervalued Diversification Can Smooth Returns And Mitigate Portfolio Risk Top Cybersecurity Stock Picks for 2025 Uptrend Stocks Explained: Learn How to Trade Using Uptrends Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for Okta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Okta and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE Ryan Specialty (NYSE:RYAN) Research Coverage Started at Morgan Stanley NEXT HEADLINE » Mobileye Global (NASDAQ:MBLY) Upgraded to Outperform at Wolfe Research You might be interested in: Head to Head Contrast: Gladstone Capital vs. Hampshire Group Chester Bancorp vs. First Capital Critical Survey MaxLinear, Inc. Receives Consensus Recommendation of “Moderate Buy” from Brokerages Crinetics Pharmaceuticals, Inc. Given Average Recommendation of “Moderate Buy” by Brokerages Contrasting Vestis & Rejuvel Bio-Sciences Critical Contrast: Yubo International Biotech and Its Rivals Daily Ratings & News for Okta Complete the form below to receive the latest headlines and analysts' recommendations for Okta with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Head to Head Contrast: Gladstone Capital (NASDAQ:GLAD) vs. Hampshire Group (OTCMKTS:HAMP) Chester Bancorp (OTCMKTS:CNBA) vs. First Capital (NASDAQ:FCAP) Critical Survey MaxLinear, Inc. (NASDAQ:MXL) Receives Consensus Recommendation of “Moderate Buy” from Brokerages Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Average Recommendation of “Moderate Buy” by Brokerages Contrasting Vestis (NYSE:VSTS) & Rejuvel Bio-Sciences (OTCMKTS:NUUU) Critical Contrast: Yubo International Biotech (YBGJ) and Its Rivals BayFirst Financial (NASDAQ:BAFN) and OFG Bancorp (NYSE:OFG) Head-To-Head Analysis Financial Analysis: The PMI Group (OTCMKTS:PPMIQ) versus NMI (NASDAQ:NMIH) Extreme Networks, Inc. (NASDAQ:EXTR) Given Average Recommendation of “Moderate Buy” by Brokerages Contrasting BEO Bancorp (OTCMKTS:BEOB) and Banco Bradesco (NYSE:BBDO) Analyzing WK Kellogg (NYSE:KLG) and Agritech Worldwide (OTCMKTS:FBER) Western Alliance Bancorporation (NYSE:WAL) Given Consensus Recommendation of “Moderate Buy” by Analysts Nio Inc – (NYSE:NIO) Receives $5.71 Average Price Target from Brokerages Gray Television, Inc. (NYSE:GTN) Given Average Rating of “Moderate Buy” by Brokerages Teleflex (NYSE:TFX) versus Accuray (NASDAQ:ARAY) Critical Contrast CIBC Upgrades Bank of Montreal (NYSE:BMO) to “Sector Outperform” InMode Ltd. (NASDAQ:INMD) Receives Average Recommendation of “Hold” from Analysts Veralto Co. (NYSE:VLTO) Receives Average Recommendation of “Hold” from Brokerages Comparing Maplebear (CART) & The Competition Head-To-Head Survey: StepStone Group (NASDAQ:STEP) vs. GCM Grosvenor (NASDAQ:GCMG) © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,Snap’s (SNAP) “Buy” Rating Reiterated at Needham & Company LLC,"Needham & Company LLC reissued their buy rating on shares of Snap (NYSE:SNAP – Free Report) in a report released on Thursday morning,Benzinga reports. Needham & Company LLC currently has a $640.00 price objective on the stock. A number of other research firms…",https://www.etfdailynews.com/2024/12/08/snaps-snap-buy-rating-reiterated-at-needham-company-llc/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/snap-inc-logo.png?v=20221104141059&w=240&h=240&zc=2,2024-12-08T07:46:49Z,"Needham &amp; Company LLC reissued their buy rating on shares of Snap (NYSE:SNAP – Free Report) in a report released on Thursday morning,Benzinga reports. Needham &amp; Company LLC currently has a $6… [+5084 chars]","Snap’s (SNAP) “Buy” Rating Reiterated at Needham & Company LLC - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options Snap’s (SNAP) “Buy” Rating Reiterated at Needham & Company LLC Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Needham & Company LLC reissued their buy rating on shares of Snap ( NYSE:SNAP – Free Report ) in a report released on Thursday morning, Benzinga reports. Needham & Company LLC currently has a $640.00 price objective on the stock. A number of other research firms have also recently weighed in on SNAP. Argus raised shares of Snap to a “hold” rating in a report on Thursday, August 8th. Truist Financial lifted their price target on shares of Snap from $13.00 to $14.00 and gave the stock a “hold” rating in a research note on Wednesday, October 30th. Piper Sandler restated a “neutral” rating and issued a $13.00 price objective (up previously from $12.00) on shares of Snap in a research note on Wednesday, October 30th. Bank of America lifted their target price on Snap from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. Finally, Loop Capital boosted their target price on Snap from $14.00 to $16.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. One analyst has rated the stock with a sell rating, twenty-two have given a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Snap has a consensus rating of “Hold” and a consensus target price of $37.10. Get Snap alerts: Check Out Our Latest Report on SNAP Snap Stock Performance Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever NYSE:SNAP opened at $12.44 on Thursday. Snap has a 12 month low of $8.29 and a 12 month high of $17.90. The company has a debt-to-equity ratio of 1.63, a current ratio of 4.04 and a quick ratio of 4.04. The firm has a market capitalization of $20.86 billion, a PE ratio of -21.45 and a beta of 0.97. The business’s fifty day moving average price is $11.23 and its 200 day moving average price is $12.19. Snap ( NYSE:SNAP – Get Free Report ) last released its quarterly earnings data on Tuesday, October 29th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Snap had a negative return on equity of 35.60% and a negative net margin of 18.49%. The business had revenue of $1.37 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the prior year, the business posted ($0.21) EPS. The business’s revenue for the quarter was up 15.4% on a year-over-year basis. On average, sell-side analysts anticipate that Snap will post -0.4 earnings per share for the current fiscal year. Insider Activity In related news, General Counsel Michael J. O’sullivan sold 59,053 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $9.29, for a total value of $548,602.37. Following the completion of the transaction, the general counsel now directly owns 1,258,278 shares of the company’s stock, valued at $11,689,402.62. This trade represents a 4.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink . Also, CTO Robert C. Murphy sold 1,000,000 shares of the business’s stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $12.50, for a total value of $12,500,000.00. Following the sale, the chief technology officer now owns 57,210,989 shares in the company, valued at approximately $715,137,362.50. The trade was a 1.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders sold 1,406,709 shares of company stock worth $16,662,107 in the last 90 days. 22.68% of the stock is currently owned by corporate insiders. Hedge Funds Weigh In On Snap Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. V Square Quantitative Management LLC acquired a new stake in shares of Snap in the third quarter valued at approximately $29,000. Paladin Wealth LLC acquired a new stake in Snap during the 3rd quarter valued at $30,000. Advisors Asset Management Inc. increased its position in Snap by 141.9% during the third quarter. Advisors Asset Management Inc. now owns 2,782 shares of the company’s stock worth $30,000 after buying an additional 1,632 shares in the last quarter. Hollencrest Capital Management acquired a new position in shares of Snap in the second quarter worth $33,000. Finally, Blue Trust Inc. lifted its position in shares of Snap by 354.1% in the second quarter. Blue Trust Inc. now owns 2,157 shares of the company’s stock valued at $36,000 after acquiring an additional 1,682 shares in the last quarter. Institutional investors and hedge funds own 47.52% of the company’s stock. Snap Company Profile ( Get Free Report ) Snap Inc operates as a technology company in North America, Europe, and internationally. The company offers Snapchat, a visual messaging application with various tabs, such as camera, visual messaging, snap map, stories, and spotlight that enable people to communicate visually through short videos and images. Featured Articles Five stocks we like better than Snap What is the NASDAQ Stock Exchange? Fast-Growing Companies That Are Still Undervalued Want to Profit on the Downtrend? Downtrends, Explained. Top Cybersecurity Stock Picks for 2025 What is a Bond Market Holiday? How to Invest and Trade Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for Snap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Snap and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE Ryan Specialty (NYSE:RYAN) Research Coverage Started at Morgan Stanley NEXT HEADLINE » Mobileye Global (NASDAQ:MBLY) Upgraded to Outperform at Wolfe Research You might be interested in: Two Harbors Investment Corp. Receives $14.18 Average PT from Analysts Fidelity National Financial, Inc. Receives $63.60 Average Price Target from Analysts Kinder Morgan, Inc. Receives Consensus Rating of “Moderate Buy” from Analysts The Chemours Company Receives Consensus Recommendation of “Hold” from Brokerages First American Financial Co. Receives Consensus Recommendation of “Moderate Buy” from Analysts Helmerich & Payne, Inc. Given Consensus Rating of “Hold” by Analysts Daily Ratings & News for Snap Complete the form below to receive the latest headlines and analysts' recommendations for Snap with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Two Harbors Investment Corp. (NYSE:TWO) Receives $14.18 Average PT from Analysts Fidelity National Financial, Inc. (NYSE:FNF) Receives $63.60 Average Price Target from Analysts Kinder Morgan, Inc. (NYSE:KMI) Receives Consensus Rating of “Moderate Buy” from Analysts The Chemours Company (NYSE:CC) Receives Consensus Recommendation of “Hold” from Brokerages First American Financial Co. (NYSE:FAF) Receives Consensus Recommendation of “Moderate Buy” from Analysts Helmerich & Payne, Inc. (NYSE:HP) Given Consensus Rating of “Hold” by Analysts Verisk Analytics, Inc. (NASDAQ:VRSK) Receives $285.80 Average Target Price from Analysts PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $51.15 Consensus Target Price from Analysts Brokerages Set Yum! Brands, Inc. (NYSE:YUM) Target Price at $145.94 Southern Copper Co. (NYSE:SCCO) Given Consensus Rating of “Reduce” by Analysts JPMorgan Chase & Co. Forecasts Strong Price Appreciation for The Goldman Sachs Group (NYSE:GS) Stock JPMorgan Chase & Co. Cuts LyondellBasell Industries (NYSE:LYB) Price Target to $90.00 What is HC Wainwright’s Estimate for KALV FY2029 Earnings? JPMorgan Chase & Co. Cuts Gold Fields (NYSE:GFI) Price Target to $17.10 JPMorgan Chase & Co. Upgrades ProPetro (NYSE:PUMP) to “Neutral” StockNews.com Upgrades Ooma (NYSE:OOMA) to Strong-Buy Foot Locker (NYSE:FL) Price Target Lowered to $29.00 at Barclays Ambarella’s (AMBA) Buy Rating Reaffirmed at Rosenblatt Securities Rosenblatt Securities Forecasts Strong Price Appreciation for Canaan (NASDAQ:CAN) Stock Morgan Stanley (NYSE:MS) Given New $104.00 Price Target at JPMorgan Chase & Co. © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,nCino (NASDAQ:NCNO) Given New $38.00 Price Target at Stephens,"nCino (NASDAQ:NCNO – Free Report) had its price target increased by Stephens from $35.00 to $38.00 in a research report sent to investors on Thursday,Benzinga reports. Stephens currently has an equal weight rating on the stock. Several other research firms al…",https://www.etfdailynews.com/2024/12/08/ncino-nasdaqncno-given-new-38-00-price-target-at-stephens/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/ncino-inc-logo.png?v=20240410092914&w=240&h=240&zc=2,2024-12-08T07:46:49Z,"nCino (NASDAQ:NCNO – Free Report) had its price target increased by Stephens from $35.00 to $38.00 in a research report sent to investors on Thursday,Benzinga reports. Stephens currently has an equal… [+4963 chars]","nCino (NASDAQ:NCNO) Given New $38.00 Price Target at Stephens - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options nCino (NASDAQ:NCNO) Given New $38.00 Price Target at Stephens Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits nCino ( NASDAQ:NCNO – Free Report ) had its price target increased by Stephens from $35.00 to $38.00 in a research report sent to investors on Thursday, Benzinga reports. Stephens currently has an equal weight rating on the stock. Several other research firms also recently weighed in on NCNO. Piper Sandler reissued an “overweight” rating and set a $38.00 target price on shares of nCino in a research report on Wednesday, August 28th. The Goldman Sachs Group upgraded nCino from a “neutral” rating to a “buy” rating and raised their target price for the stock from $34.00 to $42.00 in a research note on Wednesday, August 14th. Truist Financial reiterated a “buy” rating and set a $44.00 price target (up previously from $37.00) on shares of nCino in a research note on Monday, October 21st. Raymond James upgraded shares of nCino from a “market perform” rating to an “outperform” rating and set a $38.00 price objective on the stock in a research note on Tuesday, September 3rd. Finally, Needham & Company LLC dropped their target price on nCino from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Wednesday, August 28th. Five equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, nCino currently has an average rating of “Moderate Buy” and an average target price of $42.38. Get nCino alerts: Get Our Latest Research Report on NCNO nCino Stock Performance Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Shares of NCNO opened at $37.41 on Thursday. nCino has a 12 month low of $28.09 and a 12 month high of $43.20. The stock has a fifty day moving average price of $37.84 and a 200-day moving average price of $33.65. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.09. The firm has a market cap of $4.32 billion, a PE ratio of -220.05, a P/E/G ratio of 35.24 and a beta of 0.59. Insider Activity at nCino In other news, Director William J. Ruh sold 10,000 shares of the company’s stock in a transaction on Monday, October 21st. The shares were sold at an average price of $37.50, for a total transaction of $375,000.00. Following the completion of the sale, the director now owns 226,201 shares of the company’s stock, valued at $8,482,537.50. This represents a 4.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink . Also, Director Jeff Horing sold 1,833,975 shares of the firm’s stock in a transaction dated Friday, October 18th. The stock was sold at an average price of $36.62, for a total transaction of $67,160,164.50. Following the completion of the transaction, the director now directly owns 12,513,467 shares in the company, valued at approximately $458,243,161.54. This represents a 12.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last quarter, insiders have sold 3,235,029 shares of company stock valued at $117,599,204. 28.40% of the stock is owned by company insiders. Institutional Investors Weigh In On nCino Several hedge funds and other institutional investors have recently bought and sold shares of the company. Asset Management One Co. Ltd. grew its stake in shares of nCino by 21.1% in the 3rd quarter. Asset Management One Co. Ltd. now owns 1,956 shares of the company’s stock valued at $62,000 after buying an additional 341 shares during the period. Malaga Cove Capital LLC raised its position in nCino by 3.0% in the third quarter. Malaga Cove Capital LLC now owns 13,614 shares of the company’s stock valued at $430,000 after purchasing an additional 400 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in shares of nCino by 3.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 14,602 shares of the company’s stock valued at $459,000 after purchasing an additional 508 shares during the last quarter. Precision Wealth Strategies LLC grew its holdings in shares of nCino by 4.5% during the 3rd quarter. Precision Wealth Strategies LLC now owns 13,564 shares of the company’s stock worth $428,000 after purchasing an additional 589 shares during the period. Finally, Crewe Advisors LLC purchased a new stake in nCino in the 2nd quarter valued at about $26,000. 94.76% of the stock is currently owned by institutional investors and hedge funds. About nCino ( Get Free Report ) nCino, Inc, a software-as-a-service company, provides cloud-based software applications to financial institutions in the United States and internationally. Its nCino Bank Operating System connects financial institution employees, clients and third parties on a single cloud-based platform which include client onboarding, deposit account opening, loan origination, end-to-end mortgage suite, and powerful ecosystem. Featured Stories Five stocks we like better than nCino Following Congress Stock Trades Fast-Growing Companies That Are Still Undervalued About the Markup Calculator Top Cybersecurity Stock Picks for 2025 Are These Liquid Natural Gas Stocks Ready For An Upside Bounce? Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for nCino Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for nCino and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE Ryan Specialty (NYSE:RYAN) Research Coverage Started at Morgan Stanley NEXT HEADLINE » Mobileye Global (NASDAQ:MBLY) Upgraded to Outperform at Wolfe Research You might be interested in: Two Harbors Investment Corp. Receives $14.18 Average PT from Analysts Fidelity National Financial, Inc. Receives $63.60 Average Price Target from Analysts Kinder Morgan, Inc. Receives Consensus Rating of “Moderate Buy” from Analysts The Chemours Company Receives Consensus Recommendation of “Hold” from Brokerages First American Financial Co. Receives Consensus Recommendation of “Moderate Buy” from Analysts Helmerich & Payne, Inc. Given Consensus Rating of “Hold” by Analysts Daily Ratings & News for nCino Complete the form below to receive the latest headlines and analysts' recommendations for nCino with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Two Harbors Investment Corp. (NYSE:TWO) Receives $14.18 Average PT from Analysts Fidelity National Financial, Inc. (NYSE:FNF) Receives $63.60 Average Price Target from Analysts Kinder Morgan, Inc. (NYSE:KMI) Receives Consensus Rating of “Moderate Buy” from Analysts The Chemours Company (NYSE:CC) Receives Consensus Recommendation of “Hold” from Brokerages First American Financial Co. (NYSE:FAF) Receives Consensus Recommendation of “Moderate Buy” from Analysts Helmerich & Payne, Inc. (NYSE:HP) Given Consensus Rating of “Hold” by Analysts Verisk Analytics, Inc. (NASDAQ:VRSK) Receives $285.80 Average Target Price from Analysts PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $51.15 Consensus Target Price from Analysts Brokerages Set Yum! Brands, Inc. (NYSE:YUM) Target Price at $145.94 Southern Copper Co. (NYSE:SCCO) Given Consensus Rating of “Reduce” by Analysts JPMorgan Chase & Co. Forecasts Strong Price Appreciation for The Goldman Sachs Group (NYSE:GS) Stock JPMorgan Chase & Co. Cuts LyondellBasell Industries (NYSE:LYB) Price Target to $90.00 What is HC Wainwright’s Estimate for KALV FY2029 Earnings? JPMorgan Chase & Co. Cuts Gold Fields (NYSE:GFI) Price Target to $17.10 JPMorgan Chase & Co. Upgrades ProPetro (NYSE:PUMP) to “Neutral” StockNews.com Upgrades Ooma (NYSE:OOMA) to Strong-Buy Foot Locker (NYSE:FL) Price Target Lowered to $29.00 at Barclays Ambarella’s (AMBA) Buy Rating Reaffirmed at Rosenblatt Securities Rosenblatt Securities Forecasts Strong Price Appreciation for Canaan (NASDAQ:CAN) Stock Morgan Stanley (NYSE:MS) Given New $104.00 Price Target at JPMorgan Chase & Co. © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,Veracyte’s (VCYT) “Neutral” Rating Reiterated at The Goldman Sachs Group,"The Goldman Sachs Group reiterated their neutral rating on shares of Veracyte (NASDAQ:VCYT – Free Report) in a research note published on Thursday, Marketbeat.com reports. The Goldman Sachs Group currently has a $37.00 price target on the biotechnology compan…",https://www.etfdailynews.com/2024/12/08/veracytes-vcyt-neutral-rating-reiterated-at-the-goldman-sachs-group/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/veracyte-inc-logo.png?v=20240521134646&w=240&h=240&zc=2,2024-12-08T07:46:49Z,"The Goldman Sachs Group reiterated their neutral rating on shares of Veracyte (NASDAQ:VCYT – Free Report) in a research note published on Thursday, Marketbeat.com reports. The Goldman Sachs Group cur… [+5429 chars]","Veracyte’s (VCYT) “Neutral” Rating Reiterated at The Goldman Sachs Group - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options Veracyte’s (VCYT) “Neutral” Rating Reiterated at The Goldman Sachs Group Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits The Goldman Sachs Group reiterated their neutral rating on shares of Veracyte ( NASDAQ:VCYT – Free Report ) in a research note published on Thursday, Marketbeat.com reports. The Goldman Sachs Group currently has a $37.00 price target on the biotechnology company’s stock, down from their prior price target of $38.00. VCYT has been the topic of several other reports. Morgan Stanley boosted their price objective on shares of Veracyte from $26.00 to $28.00 and gave the stock an “underweight” rating in a research report on Monday, November 18th. Guggenheim assumed coverage on shares of Veracyte in a research note on Thursday, October 10th. They set a “buy” rating and a $40.00 price objective for the company. Leerink Partners upped their target price on Veracyte from $35.00 to $40.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Needham & Company LLC raised their price target on Veracyte from $37.00 to $44.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. Finally, Scotiabank upped their price objective on Veracyte from $40.00 to $44.00 and gave the company a “sector outperform” rating in a research report on Friday, November 8th. One analyst has rated the stock with a sell rating, one has issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $41.13. Get Veracyte alerts: View Our Latest Analysis on VCYT Veracyte Stock Up 3.0 % Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Veracyte stock opened at $44.13 on Thursday. The business has a fifty day moving average of $36.71 and a two-hundred day moving average of $29.77. The firm has a market cap of $3.42 billion, a P/E ratio of -294.20 and a beta of 1.69. Veracyte has a twelve month low of $18.61 and a twelve month high of $46.00. Veracyte ( NASDAQ:VCYT – Get Free Report ) last announced its quarterly earnings results on Wednesday, November 6th. The biotechnology company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.03 by $0.16. Veracyte had a positive return on equity of 3.02% and a negative net margin of 2.18%. The business had revenue of $115.86 million for the quarter, compared to analyst estimates of $109.81 million. During the same quarter in the previous year, the company earned ($0.03) EPS. The company’s quarterly revenue was up 28.6% on a year-over-year basis. Equities analysts expect that Veracyte will post 0.38 earnings per share for the current year. Insider Activity at Veracyte In related news, CAO Jonathan Wygant sold 5,032 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $42.89, for a total value of $215,822.48. Following the transaction, the chief accounting officer now owns 42,313 shares in the company, valued at approximately $1,814,804.57. The trade was a 10.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link . Also, Director Evan/ Fa Jones sold 5,173 shares of the stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $35.23, for a total value of $182,244.79. Following the completion of the transaction, the director now directly owns 34,343 shares of the company’s stock, valued at $1,209,903.89. This represents a 13.09 % decrease in their position. The disclosure for this sale can be found here . In the last ninety days, insiders have sold 19,211 shares of company stock worth $787,542. 1.30% of the stock is currently owned by company insiders. Hedge Funds Weigh In On Veracyte A number of institutional investors have recently made changes to their positions in the business. Eventide Asset Management LLC raised its holdings in Veracyte by 20.2% in the third quarter. Eventide Asset Management LLC now owns 677,883 shares of the biotechnology company’s stock valued at $23,075,000 after acquiring an additional 113,883 shares in the last quarter. Intech Investment Management LLC acquired a new stake in shares of Veracyte in the 3rd quarter valued at about $723,000. Erste Asset Management GmbH acquired a new position in Veracyte in the third quarter worth about $574,000. Victory Capital Management Inc. raised its stake in Veracyte by 21.8% during the second quarter. Victory Capital Management Inc. now owns 87,555 shares of the biotechnology company’s stock valued at $1,897,000 after buying an additional 15,647 shares in the last quarter. Finally, Diversified Trust Co lifted its holdings in Veracyte by 22.7% during the 2nd quarter. Diversified Trust Co now owns 28,060 shares of the biotechnology company’s stock worth $608,000 after buying an additional 5,200 shares during the last quarter. About Veracyte ( Get Free Report ) Veracyte, Inc operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. Featured Articles Five stocks we like better than Veracyte What is the S&P 500 and How It is Distinct from Other Indexes Fast-Growing Companies That Are Still Undervalued Investing in Construction Stocks Top Cybersecurity Stock Picks for 2025 Stock Ratings and Recommendations: Understanding Analyst Ratings Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for Veracyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veracyte and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE Ryan Specialty (NYSE:RYAN) Research Coverage Started at Morgan Stanley NEXT HEADLINE » Mobileye Global (NASDAQ:MBLY) Upgraded to Outperform at Wolfe Research You might be interested in: Rockefeller Capital Management L.P. Purchases 511 Shares of Datadog, Inc. Public Sector Pension Investment Board Grows Stock Holdings in Molina Healthcare, Inc. International Paper Shares Sold by Public Sector Pension Investment Board UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Five Below, Inc. Townsquare Capital LLC Makes New $174,000 Investment in Hope Bancorp, Inc. Rockefeller Capital Management L.P. Purchases Shares of 12,469 Abercrombie & Fitch Co. Daily Ratings & News for Veracyte Complete the form below to receive the latest headlines and analysts' recommendations for Veracyte with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Rockefeller Capital Management L.P. Purchases 511 Shares of Datadog, Inc. (NASDAQ:DDOG) Public Sector Pension Investment Board Grows Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH) International Paper (NYSE:IP) Shares Sold by Public Sector Pension Investment Board UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Five Below, Inc. (NASDAQ:FIVE) Townsquare Capital LLC Makes New $174,000 Investment in Hope Bancorp, Inc. (NASDAQ:HOPE) Rockefeller Capital Management L.P. Purchases Shares of 12,469 Abercrombie & Fitch Co. (NYSE:ANF) Public Sector Pension Investment Board Has $802,000 Stake in Expeditors International of Washington, Inc. (NASDAQ:EXPD) Public Sector Pension Investment Board Buys 1,200 Shares of Dollar General Co. (NYSE:DG) Capri Holdings Limited (NYSE:CPRI) Holdings Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Core & Main (NYSE:CNM) Price Target Raised to $57.00 nCino (NASDAQ:NCNO) Price Target Lowered to $42.00 at Robert W. Baird Dollar Tree (NASDAQ:DLTR) Upgraded at StockNews.com Public Sector Pension Investment Board Has $928,000 Stock Holdings in Waters Co. (NYSE:WAT) Rockefeller Capital Management L.P. Reduces Stake in Principal Financial Group, Inc. (NYSE:PFG) Public Sector Pension Investment Board Sells 5,293 Shares of Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) Public Sector Pension Investment Board Grows Holdings in Broadridge Financial Solutions, Inc. (NYSE:BR) Kellanova (NYSE:K) Shares Acquired by Public Sector Pension Investment Board Sprinklr (NYSE:CXM) Price Target Raised to $9.00 Dollar General (NYSE:DG) Rating Increased to Buy at Bank of America Asana (NYSE:ASAN) Stock Price Expected to Rise, Robert W. Baird Analyst Says © 2018-2024 ETF Daily News"
ETF Daily News,MarketBeat News,TeraWulf’s (WULF) “Buy” Rating Reiterated at Rosenblatt Securities,"Rosenblatt Securities reiterated their buy rating on shares of TeraWulf (NASDAQ:WULF – Free Report) in a research note issued to investors on Thursday,Benzinga reports. They currently have a $10.00 price objective on the stock. Several other equities research…",https://www.etfdailynews.com/2024/12/08/terawulfs-wulf-buy-rating-reiterated-at-rosenblatt-securities/,https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/terawulf-inc-logo.jpg?v=20220113215326&w=240&h=240&zc=2,2024-12-08T07:46:49Z,"Rosenblatt Securities reiterated their buy rating on shares of TeraWulf (NASDAQ:WULF – Free Report) in a research note issued to investors on Thursday,Benzinga reports. They currently have a $10.00 p… [+2942 chars]","TeraWulf’s (WULF) “Buy” Rating Reiterated at Rosenblatt Securities - ETF Daily News Skip to main content ☰ Analyst Ratings Crypto Earnings Insider Trades IPOs Options Analyst Ratings Crypto Earnings Insider Trades IPOs Options TeraWulf’s (WULF) “Buy” Rating Reiterated at Rosenblatt Securities Posted by MarketBeat News on Dec 8th, 2024 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Rosenblatt Securities reiterated their buy rating on shares of TeraWulf ( NASDAQ:WULF – Free Report ) in a research note issued to investors on Thursday, Benzinga reports. They currently have a $10.00 price objective on the stock. Several other equities research analysts also recently issued reports on the company. Stifel Canada downgraded TeraWulf from a “strong-buy” rating to a “moderate buy” rating in a report on Tuesday, October 29th. B. Riley reissued a “buy” rating and issued a $6.00 target price on shares of TeraWulf in a research report on Monday, October 7th. Cantor Fitzgerald reissued an “overweight” rating and issued a $11.00 price target on shares of TeraWulf in a research report on Wednesday. Needham & Company LLC raised their price objective on shares of TeraWulf from $6.00 to $9.50 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, Northland Securities lifted their price objective on TeraWulf from $8.00 to $10.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Seven equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $8.07. Get TeraWulf alerts: Read Our Latest Research Report on WULF TeraWulf Price Performance Want More Great Investing Ideas? 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever NASDAQ:WULF opened at $8.12 on Thursday. TeraWulf has a one year low of $1.24 and a one year high of $9.30. The firm has a 50-day moving average of $6.35 and a 200-day moving average of $4.92. Institutional Trading of TeraWulf Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Point72 Asset Management L.P. bought a new stake in shares of TeraWulf during the second quarter valued at approximately $22,443,000. Hood River Capital Management LLC purchased a new position in shares of TeraWulf during the 2nd quarter valued at about $20,532,000. Driehaus Capital Management LLC bought a new position in shares of TeraWulf in the second quarter worth approximately $9,948,000. Duquesne Family Office LLC purchased a new stake in TeraWulf in the 2nd quarter worth $9,301,000. Finally, Zweig DiMenna Associates LLC bought a new stake in TeraWulf during the 3rd quarter valued at approximately $9,489,000. Hedge funds and other institutional investors own 62.49% of the company’s stock. TeraWulf Company Profile ( Get Free Report ) TeraWulf Inc, together with its subsidiaries, operates as a digital asset technology company in the United States. The company develops, owns, and operates bitcoin mining facilities in New York and Pennsylvania. It is also involved in the provision of miner hosting services to third-party entities. The company was founded in 2021 and is headquartered in Easton, Maryland. See Also Five stocks we like better than TeraWulf Buy P&G Now, Before It Sets A New All-Time High Fast-Growing Companies That Are Still Undervalued Low PE Growth Stocks: Unlocking Investment Opportunities Top Cybersecurity Stock Picks for 2025 How to Use the MarketBeat Dividend Calculator Archer or Joby: Which Aviation Company Might Rise Fastest? Receive News & Ratings for TeraWulf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TeraWulf and related companies with MarketBeat.com's FREE daily email newsletter . « PREVIOUS HEADLINE Ryan Specialty (NYSE:RYAN) Research Coverage Started at Morgan Stanley NEXT HEADLINE » Mobileye Global (NASDAQ:MBLY) Upgraded to Outperform at Wolfe Research You might be interested in: Rockefeller Capital Management L.P. Purchases 511 Shares of Datadog, Inc. Public Sector Pension Investment Board Grows Stock Holdings in Molina Healthcare, Inc. International Paper Shares Sold by Public Sector Pension Investment Board UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Five Below, Inc. Townsquare Capital LLC Makes New $174,000 Investment in Hope Bancorp, Inc. Rockefeller Capital Management L.P. Purchases Shares of 12,469 Abercrombie & Fitch Co. Daily Ratings & News for TeraWulf Complete the form below to receive the latest headlines and analysts' recommendations for TeraWulf with MarketBeat's free daily email newsletter: Follow @etfdailynews Recent News Rockefeller Capital Management L.P. Purchases 511 Shares of Datadog, Inc. (NASDAQ:DDOG) Public Sector Pension Investment Board Grows Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH) International Paper (NYSE:IP) Shares Sold by Public Sector Pension Investment Board UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Five Below, Inc. (NASDAQ:FIVE) Townsquare Capital LLC Makes New $174,000 Investment in Hope Bancorp, Inc. (NASDAQ:HOPE) Rockefeller Capital Management L.P. Purchases Shares of 12,469 Abercrombie & Fitch Co. (NYSE:ANF) Public Sector Pension Investment Board Has $802,000 Stake in Expeditors International of Washington, Inc. (NASDAQ:EXPD) Public Sector Pension Investment Board Buys 1,200 Shares of Dollar General Co. (NYSE:DG) Capri Holdings Limited (NYSE:CPRI) Holdings Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Core & Main (NYSE:CNM) Price Target Raised to $57.00 nCino (NASDAQ:NCNO) Price Target Lowered to $42.00 at Robert W. Baird Dollar Tree (NASDAQ:DLTR) Upgraded at StockNews.com Public Sector Pension Investment Board Has $928,000 Stock Holdings in Waters Co. (NYSE:WAT) Rockefeller Capital Management L.P. Reduces Stake in Principal Financial Group, Inc. (NYSE:PFG) Public Sector Pension Investment Board Sells 5,293 Shares of Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) Public Sector Pension Investment Board Grows Holdings in Broadridge Financial Solutions, Inc. (NYSE:BR) Kellanova (NYSE:K) Shares Acquired by Public Sector Pension Investment Board Sprinklr (NYSE:CXM) Price Target Raised to $9.00 Dollar General (NYSE:DG) Rating Increased to Buy at Bank of America Asana (NYSE:ASAN) Stock Price Expected to Rise, Robert W. Baird Analyst Says © 2018-2024 ETF Daily News"
